The TRUST trial: anti-drug antibody formation in a patient with hemophilia with inhibitors after receiving the activated factor VII product Bay 86-6150

Hemophilia Comprehensive Care Center, Department of Molecular Medicine and Haematology, Faculty of Health Sciences, University of the Witwatersrand and NHLS, Johannesburg, South Africa; Department of Paediatrics, National University Hospital, Singapore, Singapore; Department of Haematology, Singapore General Hospital, Singapore, Singapore; NSHAT Haematology, Sofia, Bulgaria; Bayer Pharma AG, Berlin, Germany

Blood. 2013;122((21):):573.
Study details